Intrauterine Device Extraction - Medscape News

Two intrauterine devices (IUDs)have been approved by the FDA in the United States: the Mirena Intrauterine device (levonorgestrel-releasing intrauterine system) and the ParaGard (T380A intrauterine copper contraceptive). The levonorgestrel ...

Some Non-Pill Contraceptives Have Blood Clot Risks - US News and World Report

For women taking the pill containing the hormone levonorgestrel, the risk for a clot was three times higher, or 6.2 clots for every 10,000 years they took the pill, the researchers found. The risk to women who used a skin patch was about eight ...

Chaffin Luhana Alerts Women to Study Regarding NuvaRing and Blood Clots - PRWeb

The vaginal ring conferred a 90% higher risk of venous thrombosis than did combined oral contraceptives containing levonorgestrel, bringing the risk to the same level as that of combined oral contraceptives with third and fourth generation progestogens.

Intrauterine Devices Better Than "The Morning After Pill" As Emergency Contraception - Medical News Today

In contrast, failure rates are at least 10-20 times as high for emergency contraceptive pills such as ulipristal acetate and levonorgestrel. IUDs also offer very effective ongoing contraception. Therefore, we conclude that IUDs should be ...

ACOG: Intrauterine Device Insertion Linked to Weight Loss - Monthly Prescribing Reference

(HealthDay News) – Women who undergo postpartum or interval insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) or Copper T 380A (CU-T) intrauterine devices experience weight loss in the two years following insertion, according to a study ...

Immediate Postpartum IUD Placement Prone to Expulsion - familypracticenews.com

The expulsion rate in the immediate-placement group (12 of 22 women) was significantly higher than when the levonorgestrel-containing intrauterine device (the Mirena IUD) was placed 6 weeks postpartum or later (1 of 18 women). The finding suggests that the ...

Venous Thrombosis in Users of Non-Oral Hormonal Contraception: Follow-Up Study, Denmark 2001-10 - Medscape News

The relative risk was increased in women who used subcutaneous implants (1.4, 0.6 to 3.4) but not in those who used the levonorgestrel intrauterine system (0.6, 0.4 to 0.8). Compared with users of combined oral contraceptives containing ...

Contraceptive patches and vaginal rings ‘double thrombosis risk’ - Pulse

Experts warned the ‘extremely concerning' study results could undo years of work reducing teenage pregnancies, but the authors urged GPs to use oral levonorgestrel or norgestimate- based contraceptives to reduce the risk of VTEs. The Danish researchers ...

Study Confirms Blood Clot Risk with NuvaRing, Ortho Evra Birth Control - AboutLawsuits.com

After examining data on more than 1.6 million Danish women, the study found that when compared to use of levonorgestrel-based oral contraceptives NuvaRing and Ortho Evra may double the risk of venous thrombosis, which involves blood clots that cause a deep ...